How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
Guest Host: Frank Sesno
An examination of the Vioxx drug scandal, whether it could happen again, and how consumers can protect themselves.
- Tom Nesi A "patient advocate" for the FDA and former pharmaceutical executive, including a consultant for Merck.
- Gardiner Harris Science reporter for "The New York Times"
- Ted Mayer A partner at Hughes Hubbard & Reed, who has been involved with the Vioxx litigation from the beginning.
- Bert Rein A partner at Wiley Rein, who argued the Wyeth v. Levine case up through the Vermont Supreme Court.
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.